Sanpeng Xu

1.5k total citations
32 papers, 508 citations indexed

About

Sanpeng Xu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sanpeng Xu has authored 32 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sanpeng Xu's work include Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Sanpeng Xu is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Sanpeng Xu collaborates with scholars based in China, United States and United Kingdom. Sanpeng Xu's co-authors include Shiying Yuan, You Shang, Shanglong Yao, Guoping Wang, Zhouyang Wu, Yaqi Duan, Jie Wang, Peipei Guo, Dong Kuang and Shanglong Yao and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Oncotarget.

In The Last Decade

Sanpeng Xu

32 papers receiving 498 citations

Peers

Countries citing papers authored by Sanpeng Xu

Since Specialization

Citations

This map shows the geographic impact of Sanpeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanpeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanpeng Xu more than expected).

Fields of papers citing papers by Sanpeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanpeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanpeng Xu. The network helps show where Sanpeng Xu may publish in the future.

Co-authorship network of co-authors of Sanpeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Sanpeng Xu. A scholar is included among the top collaborators of Sanpeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanpeng Xu. Sanpeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins 2025 ·Emerging Microbes & Infections ·Jian Wu, Sanpeng Xu, Zhiqing Li, (unknown), Zongheng Yang, (unknown), Wan-Feng Gao, Shuo Liu, Yu Zhou, Sheng Xu, Nan Li, Jin Hou, Guoping Wang, Xuetao Cao, (unknown), (unknown)	1
2	SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors 2022 ·Diagnostic Pathology ·(unknown), Yuting Dong, (unknown), Sanpeng Xu, Guoping Wang, Dong Kuang, Yaqi Duan	3
3	CircRNA circ_0092314 Induces Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells via Elevating the Expression of S100P by Sponging miR-671 2021 ·Frontiers in Oncology ·Qian Shen, Gang Zheng, (unknown), Jin Tong, Sanpeng Xu, Hui Gao, Xiaofan Zhang, Qiang Fu	26
4	[Pathological changes with novel coronavirus infection in lung cancer surgical specimen]. 2020 ·PubMed ·Dong Kuang, Sanpeng Xu, Yu Hu, Cong Liu, (unknown), Guoping Wang	6
5	SOX11 inhibits tumor proliferation and promotes cell adhesion mediated-drug resistance via a CD43 dependent manner in mantle cell lymphoma 2020 ·Leukemia & lymphoma ·(unknown), (unknown), Yaqi Duan, (unknown), (unknown), (unknown), (unknown), Qian Zhang, Sanpeng Xu, (unknown), Dong Kuang, Guoping Wang	2
6	Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Haijing Liu, Yingyong Hou, Xiaoyan Zhou, Li Liang, Zhihong Zhang, Huaiyin Shi, Sanpeng Xu, Peizhen Hu, (unknown), Rui Liu, (unknown), Feng Ye, Zhiyong Liang, Hong Bu	14
7	Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ 2018 ·Current Medical Science ·(unknown), Lili Yang, (unknown), Sanpeng Xu, Chengfeng Yang, (unknown), (unknown), Qiurong Ruan	12
8	Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro 2018 ·Journal of Cancer ·Lin Yang, Guanghai Yang, Yingjun Ding, (unknown), Sanpeng Xu, Qiuyun Guo, (unknown), Guangyuan Hu	32
9	miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT 2018 ·Cell Communication and Signaling ·Yu Wang, Jun Li, Dong Kuang, Xiaoyan Wang, Yuanli Zhu, Sanpeng Xu, Yaobing Chen, (unknown), Qiu Zhao, Yaqi Duan, Guoping Wang	34
10	An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report 2016 ·Diagnostic Pathology ·(unknown), Jun Li, Sanpeng Xu, (unknown), Guoping Wang, Yaqi Duan	7
11	Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay 2016 ·Oncology Letters ·Sanpeng Xu, Yaqi Duan, (unknown), (unknown), (unknown), Guoping Wang	9
12	Frequently rearranged in advanced T-cell lymphomas-1 demonstrates oncogenic properties in prostate cancer 2016 ·Molecular Medicine Reports ·Wei Zhang, Hua Xiong, Yanmei Zou, Sanpeng Xu, Lanping Quan, Xianglin Yuan, Ningzhi Xu, Yihua Wang	2
13	The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination 2014 ·Polish Journal of Pathology ·(unknown), Sanpeng Xu, (unknown), Chao Zhang, (unknown), Xi Wang, (unknown)	24
14	Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines 2014 ·Scientific Reports ·Liu Huang, Fengju Chen, Yangyang Chen, Xiaomei Yang, Sanpeng Xu, Shuwang Ge, Shengling Fu, Tengfei Chao, Qianqian Yu, Xin Liao, Guangyuan Hu, Peng Zhang, Xianglin Yuan	11
15	[Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast]. 2013 ·PubMed ·Ming Yang, Sanpeng Xu, Qilin Ao	4
16	Mucinous cystadenocarcinoma of the breast with a basal‐like immunophenotype 2012 ·Pathology International ·Yunte Deng, (unknown), Xiaoyan Wang, Sanpeng Xu, Qilin Ao, Zhiyong Hu, Guoping Wang	23
17	The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway 2010 ·Biochemical and Biophysical Research Communications ·Yanling Liu, Sanpeng Xu, Fei Xiao, Yan Xiong, Xiaojin Wang, (unknown), Weiming Yan, Qin Ning	32
18	Neuroprotective Effect of Lipoxin A4 Methyl Ester in a Rat Model of Permanent Focal Cerebral Ischemia 2010 ·Journal of Molecular Neuroscience ·Yan Wu, (unknown), Peipei Guo, Sanpeng Xu, Jie Wang, Shiying Yuan, Shanglong Yao, You Shang	44
19	Melatonin reduces acute lung injury in endotoxemic rats. 2009 ·PubMed ·You Shang, Sanpeng Xu, (unknown), (unknown), Zhouyang Wu, Shiying Yuan, Shanglong Yao	62
20	Rearranged T-cell receptor gene and positive Epstein–Barr virus-encoded nuclear RNA in an extranodal NK/T-cell lymphoma with cutaneous manifestation only: case study 2007 ·Clinical and Experimental Dermatology ·(unknown), (unknown), (unknown), (unknown), Sanpeng Xu, (unknown), Xiaofei Mo, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact